The purpose of this study was to evaluate the effect of structured self-monitoring of blood glucose (SMBG) on patient self-management behavior and metabolic outcomes in patients with type 2 diabetes mellitus (T2DM).
Methods:
From January to June 2009, 30 patients with basic diabetes education were followed for a period of 90 days. To provide assessment of glycemic control and frequency of dysglycemia, patients, underwent 3 consecutive days of seven-point SMBG during each month for 3 consecutive months, using the ACCU-CHEK 360° View tool. Glucose profiles of the first and third month were used for comparison.
Results:
Hemoglobin A1c (HbA1c) improved significantly during the 90-day period in all patients [confidence interval (CI) 95%, 0.32–1.64%, p < .05] and those with poor metabolic control (group B; CI 95%, 0.86–2.64%, p < .05). Mean blood glucose (MBG) values decreased significantly in group B (CI 95%, 0.56–24.78 mg/dl, p < .05) and all cases (CI 95%, 1.61–19.73 mg/dl, p < .05). Meanwhile, there was an average decrease of 15.7 mg/dl in fasting blood sugar (FBS) levels in the whole subjects. Mean postprandial blood glucose levels (MPP) decreased by 19.3 and 11.3 mg/dl in group B and in all cases, respectively. However, there were no significant changes in HbA1c, MBG, FBS, and MPP in people with good metabolic control.
Conclusion:
A structured SMBG program improves HbA1c, FBS, MPP, and MBG in people with poorly controlled diabetes. This improvement shows the importance of patient self-management behavior on metabolic outcomes in T2DM.
EsteghamatiAGouyaMMAbbasiMDelavariAAlikhaniSAlaediniFSafaieAForouzanfarMGreggEW. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care.2008;31 (1): 96–8.
4.
KhuntiKGadsbyRMillettCMajeedADaviesM. Quality of diabetes care in the UK: Comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med.2007;24 (12): 1436–41.
5.
HirschIBBrownleeM. Should minimal blood glucose variability become the gold standard of glycemic control?J Diabetes Complications.2005;19 (3): 178–81.
6.
Del PratoS. In search of normoglycaemia in diabetes: Controlling postprandial glucose. Int J Obes Relat Metab Disord.2002;26 (Suppl 3): S9–17.
7.
MonnierLColetteC. Glycemic variability: Should we and can we prevent it?Diabetes Care.2008;31 (Suppl 2): S150–4.
CavalotFPetrelliATraversaMBonomoKFioraEContiMAnfossiGCostaGTrovatiM. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab.2006;91 (3): 813–9.
10.
BrownleeM. The pathobiology of diabetic complications: A unifying mechanism. Diabetes.2005;54 (6): 1615–25.
11.
PistroschFReissmannEWildbrettJKoehlerCHanefeldM. Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Am J Hypertens.2007;20 (5): 541–5.
RenardE. Monitoring glycemic control: The importance of self-monitoring of blood glucose. Am J Med.2005;118 (Suppl 9A): 12S–19S.
14.
GoldsteinDELittleRRLorenzRAMaloneJINathanDPetersonCMSacksDB. Tests of glycemia in diabetes. Diabetes Care.2004;27 (7): 1761–73.
15.
MonnierLColetteCLapinskiHBonifaceH. Self-monitoring of blood glucose in diabetic patients: From the least common denominator to the greatest common multiple. Diabetes Metab.2004;30 (2): 113–9.
16.
TsengKH. Standards of medical care in diabetes–2006: Response to the American Diabetes Association. Diabetes Care.2006;29 (11): 2563–4.
17.
KlonoffDCBergenstalRBlondeLBorenSAChurchTSGaffaneyJJovanovicLKendallDMKollmanCKovatchevBPLeippertCOwensDRPolonskyWHReachGRenardERiddellMCRubinRRSchnellOSiminieroLMVigerskyRAWilsonDMWollitzerAO. Consensus report of the Coalition for Clinical Research—Self-Monitoring of Blood Glucose. J Diabetes Sci Technol.2008;2 (6): 1030–53.
18.
IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: Recommendations for standard, comprehensive, and minimal care. Diabet Med.2006;23 (6): 579–93.
19.
KarterAJAckersonLMDarbinianJAD'AgostinoRBJrFerraraALiuJSelbyJV. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes registry. Am J Med.2001;111 (1): 1–9.
20.
HarrisMI; National Health and Nutrition Examination Survey (NHANES III). Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care.2001;24 (6): 979–82.
21.
SchwedesUSieboldsMMertesG; SMBG Study Group. Meal-related structured self-monitoring of blood glucose: Effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care.2002;25 (11): 1928–32.
22.
PolonskyWFisherLSchikmanCHinnenDParkinCJelsovskyZAmstutzLSchweitzerMWagnerR. The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: Design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986]. BMC Fam Pract.2010;18; 11: 37.
23.
GuerciBDrouinPGrangéVBougnèresPFontainePKerlanVPassaPThivoletChVialettesBCharbonnelB; ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab.2003;29 (6): 587–94.
24.
RuttenGvan EijkJde NobelEBeekMvan der VeldenH. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam Pract.1990;7 (4): 273–8.
25.
BarnettAHKrentzAJStrojekKSieradzkiJAziziFEmbongMImamogluSPerusicováJUlicianskyVWinklerG. The effcacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab.2008;10 (12): 1239–47.
26.
FarmerAWadeAGoyderEYudkinPFrenchDCravenAHolmanRKinmonthALNeilA. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: Open parallel group randomised trial. BMJ.2007;335 (7611): 132.
27.
FontbonneABillaultBAcostaMPercheronCVarennePBesseAEschwegeEMonnierLSlamaGPassaP. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab.1989;15 (5): 255–60.
28.
AllenBTDeLongERFeussnerJR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care.1990;13 (10): 1044–50.
29.
O'KaneMJBuntingBCopelandMCoatesVE; ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): Randomised controlled trial. BMJ.2008;336 (7654): 1174–7.
30.
WingRREpsteinLHNowalkMPScottNKoeskeRHaggS. Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes?Am J Med.1986;81 (5): 830–6.
31.
AikensJEBinghamRPietteJD. Patient-provider communication and self-care behavior among type 2 diabetes patients. Diabetes Educ.2005;31 (5): 681–90.
32.
SánchezCDNewbyLKMcGuireDKHasselbladVFeinglosMNOhmanEM. Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes. Am J Cardiol.2005;95 (11): 1290–4.
33.
BazataDDRobinsonJGFoxKMGrandyS; SHIELD Study Group. Affecting behavior change in individuals with diabetes: Findings from the Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes (SHIELD). Diabetes Educ.2008;34 (6): 1025–36.
